Scopia Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-3,659,647
| Closed | -$75.3M | – | 44 |
|
|
2016
Q3 | $75.3M | Sell |
3,659,647
-994,680
| -21% | -$20.5M | 1.33% | 21 |
|
|
2016
Q2 | $142M | Sell |
4,654,327
-749,335
| -14% | -$22.9M | 2.94% | 11 |
|
|
2016
Q1 | $202M | Sell |
5,403,662
-1,055,477
| -16% | -$39.5M | 3.77% | 6 |
|
|
2015
Q4 | $279M | Sell |
6,459,139
-324,113
| -5% | -$14M | 5.53% | 5 |
|
|
2015
Q3 | $254M | Buy |
6,783,252
+297,026
| +5% | +$11.1M | 5.45% | 5 |
|
|
2015
Q2 | $220M | Buy |
6,486,226
+676,427
| +12% | +$23M | 4.28% | 7 |
|
|
2015
Q1 | $206M | Buy |
5,809,799
+1,633,725
| +39% | +$57.8M | 4.45% | 7 |
|
|
2014
Q4 | $142M | Buy |
4,176,074
+1,604,113
| +62% | +$54.6M | 2.65% | 11 |
|
|
2014
Q3 | $99.2M | Sell |
2,571,961
-279,306
| -10% | -$10.8M | 2.02% | 13 |
|
|
2014
Q2 | $111M | Buy |
2,851,267
+521,314
| +22% | +$20.3M | 2.86% | 9 |
|
|
2014
Q1 | $79.7M | Buy |
2,329,953
+1,567,553
| +206% | +$53.6M | 2.53% | 11 |
|
|
2013
Q4 | $16M | Buy |
+762,400
| New | +$16M | 0.49% | 19 |
|